期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺动脉高压的治疗新策略 被引量：5

在线阅读 下载PDF
导出
摘要 肺动脉高压（pulmonary artery hypertension，PAH）是指以肺血管阻力进行性升高为特征．最终导致右心衰竭甚至死亡的一组疾病。其病理基础以肺动脉和肺静脉中层肥厚、内膜增生、原位血栓形成和血管丛状改变为特征病变。其临床定义为肺动脉平均压在静息状态下≥25mmHg，或者在运动时≥30mmHg。近几年众多学者对PAH发生机制的研究取得了较大进步，2003年第三次世界肺动脉高压会议又对PAH重新进行了临床分类：
作者 陈海燕 白元
机构地区 第二军医大学附属长征医院心内科 第二军医大学附属长海医院心内科
出处 《实用医学杂志》 CAS 2008年第20期3455-3457,共3页 The Journal of Practical Medicine
关键词 肺动脉高压 PULMONARY 肺血管阻力 治疗 ARTERY 肺动脉平均压 临床分类 右心衰竭
分类号 R543 [医药卫生—心血管疾病]
  • 相关文献

参考文献30

  • 1无.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35(11):979-987. 被引量：276
  • 2D'Alonzo G E, Barst R J, Ayres S M, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry [J]. Ann Intern Med, 1991,115(5) :343-349.
  • 3Treprostinil Study Group. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension., a double-blind, randomized, placebocontrolled trial [ J ]. Am J Respir Crit Care Med, 2002,165 (6) : 800-804.
  • 4Treprostinil Study Group. Efficacy and safety of treprostinil: epoprostenol analog for primary pulmonary hypertension [J]. Cardiovasc Pharmacol, 2003,41 (2) : 293-299.
  • 5Gomberg-Maitland M, Tapson V F, Benza R L, et al. Transition from intravenous epoprostenol to intravenous treprostinil inpulmonary hypertension [J]. Am J Respir Crit Care Med,2005,172 (12): 1586-1589.
  • 6Hoeper M M, Olschewski H, Ghofrani H A, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension: German PPH study group [J]. J Am Coll Cardiol, 2000,35( 1 ) : 176-182.
  • 7Hoeper M M, Schwarze M, Ehlerding S, et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostaeyelin analogue [J]. N Engl J Med, 2000, 342 (25) :1866- 1870.
  • 8Nagaya N, Uematsu M, Okano Y, et al. Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension [J]. J Am Coll Cardiol,1999,34 (4): 1188-1192.
  • 9Beraprost Study Group. Beraprost therapy for pulmonary arterial hypertension [J]. J Am Coll Cardio, 2003,41 (12) : 2119-2125.
  • 10Cacoub P, Dorent R, Maistre G, et al. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome [J]. Am J Cardiol, 1993,71 (5) : 448-450.

二级参考文献31

  • 1荆志成,徐希奇.肺动脉高压现代分类和诊断策略[J].中华心血管病杂志,2004,32(12):1160-1162. 被引量：40
  • 2荆志成.六分钟步行距离试验的临床应用[J].中华心血管病杂志,2006,34(4):381-384. 被引量：98
  • 3Proceeding of 3rd World Symposium on Pulmonary Arterial Hypertension. Venice, Italy, June 23-25, 2003. J Am Coll Cardiol, 2004,43(2 Suppl S) : 1S-90S.
  • 4Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest, 2004, 126( Suppl 1 ) : 1 S-92S.
  • 5Galie N, Torbicki A, Barst A, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J, 2004,25 ( 24 ) : 2243-2278.
  • 6Barst RJ, McGoon M, Torbicki A,et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol, 2004,43( 12 Suppl S) :40S-47S.
  • 7Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol, 2004,43 (12) :5S-12S.
  • 8Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol, 2004,43(12 Suppl S) :25S-32S.
  • 9McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines. Chest, 2004,126 (1 Suppl): 14S-34S.
  • 10Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med, 2006,173 (9) :1023-1030.

共引文献275

同被引文献66

  • 1荆志成,吴艳,徐希奇,邓可武,胡大一.美国胸科医师学院肺动脉高压内科治疗指南介绍(1)[J].中国医药导刊,2005,7(2):137-141. 被引量：4
  • 2侯凡,李震一,孟素荣,李爱民,张晓燕,祝善俊.前列腺素E_1对风湿性二尖瓣病变合并肺动脉高压患者血液动力学的影响[J].中国循环杂志,1995,10(10):591-593. 被引量：13
  • 3张燕,张竹花,金征宇,张云庆,齐冰,梁继祥,朱海峰,赵文敏,王沄.多层螺旋CT在肺动脉高压诊断中的应用[J].中国医学科学院学报,2006,28(1):44-48. 被引量：9
  • 4陆慰萱,王辰.肺循环病学[M].北京:人民卫生出版社,2007:657-661.
  • 5Pacher R, Stanek B, Hulsmann M, et al. Effect of prostaglandin E1 infusion in severe chronic heart failure [J]. Prostaglandins, 1997, 53(4) :221-235.
  • 6Kunimoto F, Arai K, Isa Y K, et al. A comprartive study of vasodilator effects of PGE1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome [J]. Anesth Analg, 1997, 85(3) :507-513.
  • 7Sakuma F, Miyata M, Kasukawa K, et al. Suppressive effect of progtaglandin El on pulmonary hypertension induced by monocrotaline in rats [J]. Lung, 1999, 177(2):77-78.
  • 8Sanchez O, Sitbon O, Jais X, et al. Immunosuppressive Therapy in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension [J].Chest,2006,130( 1 ) : 182-189.
  • 9Ogawa A, Nakamura K, Matsubara H, et al. Prednisolone Inhibits Proliferation of Cultured Pulmonary Artery Smooth Muscle Cells of Patients With Idiopathic Pulmonary Arterial Hypertension [J]. Circulation, 2005,112 ( 12 ) : 1806 - 1812.
  • 10Ghofrani HA, Wilkins MW, Rich S. Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension [ J ]. Circulation, 2008,118 ( 11 ) : 1195-1201.

引证文献5

二级引证文献11

实用医学杂志
2008年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部